Sutro Biopharma Inc
STRO
Market Cap$61.99M
Close$
$-0.57
183.7% downside
Current Fair Value
183.7% downsideOvervalued by 183.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $61.99 Million |
|---|---|
| Enterprise Value | $46.14 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-2.96 |
| Beta | 1.71 |
| Outstanding Shares | 83,106,013 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -0.25 |
|---|---|
| PEG | -0.82 |
| Price to Sales | - |
| Price to Book Ratio | -0.68 |
| Enterprise Value to Revenue | 0.69 |
| Enterprise Value to EBIT | -0.19 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.96 |
| Debt to Equity | -3.5 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Sutro Biopharma Inc
CEO: William Newell